click here! DEB | NICHD | NIH | DHHS | FIRSTGOV  © 2001-2006 National Institute of Child Health and Human Development
  • Home
  • Carney Complex Research
    • Information About Carney Complex
    • Diagnosis of Carney Complex
    • Carney Complex Gene
  • Clinical Research
    • Pituitary Tumors
    • Genetic Endocrine Conditions
    • Adrenal Tumor Studies
    • Work of SEGEN on Phosphodieserases new
    • ACTH-Independent Steroid Hormones
    • Other Genetic Syndromes
    • How to Refer a Patient
  • Ongoing Laboratory Research
    • 2005 Annual Report of DIR
    • Segen Mouse Models
    • Meetings
    • Laboratory Life and Functions
  • Publications
    • Carney Complex
    • Pituitary Tumors
    • Adrenal Tumors and Adrenal Cancer
    • Hyperaldosteronism
    • Genetic Syndromes
  • Personnel
    • Constantine A. Stratakis, M.D., D.Sc.
    • A. Bauer, M.D.
    • S. Boikos, M.D.
    • C. Giatzakis, M.D.
    • A. Horvath, Ph.D.
    • H. Hsaio, M.D.
    • M. Muchow, Ph.D.
    • A. Robinson-White, Ph.D.
    • S. Heyerdahl, B.S.
    • E. Levine, B.S.
    • E. Stein, B.S.
    • Volunteers or visiting scientists
    • SEGEN Graduates: Where are they now?
  • Contact us
    • Contact Information
    • Positions Available at SEGEN
  • Ask Constantine!
  • Links
    • Oncolink
    • Endonews
    • The Endocrine Society
    • NIH Loan Repayment Program for Our Fellows

SEGEN Mouse Models

Articles

A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.  (PDF)

Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.  (PDF)

A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.  (PDF)